Profile photo Nadia Haj Mohammad

Nadia Haj Mohammad

Assistant Professor - medical

Strategic program(s):

Biography

Dr. N. Haj Mohammad (1976) has been working as a medical oncologist in the UMC Utrecht since 2014. She studied pharmacy in the same city, and completed her pharmacy training in 2001. One year earlier, she started Medical school at the University of Amsterdam. She combined her training as a medical-oncologist at the AMC with PhD research in the clinical outcomes of treatments for gastroesophageal and pancreatic carcinoma.

She is member of the national guidelines for hepatocellular carcinoma and bile duct carcinoma. She is a board member of the Dutch Upper GI Cancer group.

Her research focuses on clinical outcomes of gastroesophageal and primary liver cancers. She is national PI of the phase 2 LyRICX study in metastatic gastroesophageal cancer and is local PI of multiple investigator and sponsor investigated studies within tumors of the upper digestive tract and primary liver tumors.

Strategic program(s):

Contact

Research groups

Primary Liver Tumors research group

Research aim

To improve surveillance, diagnostics, treatment, and outcome for patients with primary liver tumors (hepatocellular carcinoma and cholangiocarcinoma) by interdisciplinary and (inter-)national collaborative research

Go to group

Recent publications

Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma Charlotte I Stroes, Sybren L Meijer, Geert-Jan Creemers, Gerrit K J Hooijer, Nadia Haj Mohammad, Maartje Los, Marije Slingerland, Geke A P Hospers, Annemieke Cats, Laurens V Beerepoot, Maarten F Bijlsma, Hanneke W M van Laarhoven
Translational Oncology, 2024, vol. 49
Measurement of metabolite levels and treatment-induced changes in hepatic metastases of gastro-esophageal cancer using 7-T phosphorus magnetic resonance spectroscopic imaging Lieke van den Wildenberg, Bobby A Runderkamp, Leonard W F Seelen, Hanneke W M van Laarhoven, Mark W J M Gosselink, Wybe J M van der Kemp, Nadia Haj Mohammad, Dennis W J Klomp, Jeanine J Prompers
NMR in Biomedicine, 2024, vol. 37
Correction L. A. Daamen, I. W.J.M. van Goor, V. P. Groot, P. C.M. Andel, L. A.A. Brosens, O. R. Busch, G. A. Cirkel, N. Haj Mohammad, H. D. Heerkens, I. H.J.T. de Hingh, F. Hoogwater, H. W.M. van Laarhoven, M. Los, G. J. Meijer, V. E. de Meijer, R. Pande, K. J. Roberts, J. Stoker, M. W.J. Stommel, G. van Tienhoven, R. C. Verdonk, H. M. Verkooijen, F. J. Wessels, J. W. Wilmink, M. G. Besselink, H. C. van Santvoort, M. P.W. Intven, I. Q. Molenaar,
Trials, 2024, vol. 25
Evaluation of treatment strategies and survival of patients with cT4bM0 esophageal cancer Jingpu Wang, Eline M de Groot, Zhouqiao Wu, Rob H A Verhoeven, Nadia Haj Mohammad, Stella Mook, Lucas Goense, Sheraz R Markar, Jelle P Ruurda, Richard van Hillegersberg
Digestive Surgery, 2024, vol. 41, p.171-180
Fecal, Duodenal and Tumor Microbiota Composition of Esophageal Carcinoma Patients, a Longitudinal Prospective Cohort Tom van den Ende, Nicolien C de Clercq, Mark Davids, Ruben Goedegebuure, Benthe H Doeve, Gati Ebrahimi, Jeroen Buijsen, Ronald Hoekstra, Nadia Haj Mohammad, Maarten F Bijlsma, Max Nieuwdorp, Hanneke W M van Laarhoven
Journal of the National Cancer Institute, 2024, vol. 116, p.1834-1844
Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal Cancer Merel J M van Velzen, Marieke Pape, Mirjam A G Sprangers, Jessy Joy van Kleef, Bianca Mostert, Laurens V Beerepoot, Marije Slingerland, Elske C Gootjes, Ronald Hoekstra, Lonneke V van de Poll-Franse, Nadia Haj Mohammad, Hanneke W M van Laarhoven
Journal of the national comprehensive cancer network, 2024, vol. 22, p.455-461